Our global pages
Close- Global home
- About us
- Global services/practices
- Industries/sectors
- Our people
- Events/webinars
- News and articles
- Eversheds Sutherland (International) Press Hub
- Eversheds Sutherland (US) Press Hub
- News and articles: choose a location
- Careers
- Careers with Eversheds Sutherland
- Careers: choose a location
Eversheds Sutherland has advised Senzime
- Sweden
01-06-2022
Eversheds Sutherland has advised Senzime AB (publ), listed on Nasdaq Stockholm, in connection with the entering into of an agreement to acquire 100 percent of the shares in the Boston-based US company Respiratory Motion, Inc. for an initial consideration of USD 19 million on a cash- and debt-free basis with an additional potential earn-out payment of up to USD 25 million. The total consideration is payable in Senzime shares and/or cash.
Through the acquisition, Senzime expands its product portfolio within the market for monitoring of vital signs and extends its capability to capture a larger share of the patient journey outside of the operating room as well.
This information is for guidance purposes only and should not be regarded as a substitute for taking legal advice. Please refer to the full terms and conditions on our website.
- SAIIPL Submission on the Copyright and Performers Protection Bills To The NCOP
- Eversheds Sutherland opens new office in San Francisco
- Eversheds Sutherland advises GuarantCo to boost infrastructure development in West Africa
- Webinar: Board Members’ and Director’s liability, how to mitigate the risks.
- Restrictive Covenants